Hegele Ra
Robarts Research Institute and University of Western Ontario, London, Ontario, Canada.
Clin Genet. 2005 Jul;68(1):31-4. doi: 10.1111/j.1399-0004.2005.00447.x.
The underlying disease mechanisms likely include mutation effects on the nuclear envelope and on interactions between lamins and transcription factors. At the same time, can a simple genomic attribute -- for instance, mutation position within the LMNA sequence -- predict the complex phenotypic effects? In order to assess this, hierarchical cluster analysis (HCA) was used for assembling 16 laminopathies into two classes based on organ system involvement. Ninety-one reported causative LMNA mutations in these laminopathies were then classified according to their position upstream or downstream of the nuclear localization signal sequence (NLS). Contingency analysis was used in order to assess a non-random relationship between HCA laminopathy class and LMNA mutation position relative to the NLS. HCA laminopathy class and LMNA mutation position were strongly associated (p < 0.0001). The odds ratio for general association between an HCA class 1 laminopathy and a mutation upstream of the NLS sequence was 8.4 (95% confidence interval = 2.9 - 24.7, p < 0.0001). Although the underlying molecular biology is complex, the findings support the hypothesis that laminopathy phenotype and LMNA genotype are non-randomly associated. Furthermore, HCA may be a tool to help with the study of phenotype - genotype associations, or 'phenomics'.
潜在的疾病机制可能包括对核膜以及核纤层蛋白与转录因子之间相互作用的突变影响。与此同时,一个简单的基因组属性——例如,LMNA序列内的突变位置——能否预测复杂的表型效应呢?为了评估这一点,基于器官系统受累情况,采用层次聚类分析(HCA)将16种核纤层蛋白病分为两类。然后,根据这些核纤层蛋白病中91个已报道的致病性LMNA突变在核定位信号序列(NLS)上游或下游的位置进行分类。使用列联分析来评估HCA核纤层蛋白病类别与相对于NLS的LMNA突变位置之间的非随机关系。HCA核纤层蛋白病类别与LMNA突变位置密切相关(p < 0.0001)。HCA 1类核纤层蛋白病与NLS序列上游突变之间的总体关联优势比为8.4(95%置信区间 = 2.9 - 24.7,p < 0.0001)。尽管潜在的分子生物学很复杂,但这些发现支持了核纤层蛋白病表型与LMNA基因型非随机相关的假设。此外,HCA可能是一种有助于研究表型 - 基因型关联或“表型组学”的工具。